REAL-WORLD NON-PERSISTENCE WITH ORAL MULTIPLE MYELOMA TREATMENTS: A COMPARATIVE ANALYSIS OF METHODOLOGIES USING CLAIMS DATA

被引：0
|
作者：
Kocaata, Z. [1 ]
Mueller, S. [2 ]
Maywald, U. [3 ]
Wilke, T. [4 ]
机构：
[1] Ingress Hlth HWM GmbH, Wismar, MV, Germany
[2] Ingress Hlth, Wismar, Germany
[3] AOK PLUS, Dresden, Germany
[4] IPAM eV, Wismar, Germany
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN156
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [31] Osteonecrosis of the jaw secondary to bisphosphonate treatment in multiple myeloma - real-world data
    Vanhinsbergh, L.
    Husain, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 246 - 246
  • [32] Comparative analysis of real-world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study
    Chastek, Benjamin
    Carrera, Adam
    Landis, Christina
    Snyder, Daniel
    Abedinzadeh, Laleh
    Bancroft, Tim
    Nesheim, Jeffrey
    Kennelly, Michael
    Staskin, David
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (07) : 1504 - 1513
  • [33] Real-World Treatment Patterns, Outcomes, Health Care Resource Utilization and Cost Burden of Multiple Myeloma in South Korea Using the National Claims Data
    Park, YoungJu
    Park, Sung Soo
    Yoon, Soomin
    Jeong, Jihyeon
    Lee, Doik
    Kim, Kihyun
    BLOOD, 2023, 142
  • [34] Real-World Outcomes for Standard-ofCare Treatments in Patients with Relapsed/Refractory Multiple Myeloma
    Delforge, Michael
    Vekemans, Marie-Christiane
    Anguille, Sebastien
    Depaus, Julien
    Meuleman, Nathalie
    Van de Velde, Ann
    Van de Broek, Isabelle
    Strens, Danielle
    Van Hoorenbeeck, Sandra
    Moorkens, Evelien J.
    Diels, Jorks
    Ghilotti, Francesca
    Dalhuisen, Sander
    Vandervennet, Sophie
    BLOOD, 2021, 138
  • [35] Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data
    Liu, Emily I.
    Sweeney, Nathan W.
    Ahlstrom, Jennifer M.
    BLOOD, 2021, 138 : 3778 - +
  • [36] Real-World Persistence with and Adherence to Emicizumab Prophylaxis in Persons with Hemophilia a: A Secondary Claims Database Analysis
    Mahajerin, Arash
    Khairnar, Rahul
    Meyer, Craig S.
    Abbass, Ibrahim M.
    Wang, Rongrong
    Lee, Lucy
    Tzeng, Eunice
    Raimundo, Karina
    BLOOD, 2020, 136
  • [37] Real-World Comparative Effectiveness and Persistence of Cladribine Tablets and Other Oral Disease-Modifying Treatments for Multiple Sclerosis from GLIMPSE: Results from the MSBase Registry
    Butzkueven, H.
    Spelman, T.
    Ozakbas, S.
    Alroughani, R.
    Terzi, M.
    Hodgkinson, S.
    Laureys, G.
    Kalincik, T.
    Van der Walt, A.
    Yamout, B.
    Lechner-Scott, J.
    Soysal, A.
    Kuhle, J.
    Sanchez-Menoyo, J.
    Blanco, Y.
    Spitaleri, D.
    Van Pesch, V.
    Horakova, D.
    Ampapa, R.
    Patti, F.
    Macdonell, R.
    Al-Asmi, A.
    Gerlach, O.
    Oh, J.
    Altintas, A.
    Tundia, N.
    Wong, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 176 - 177
  • [38] Identification of cancer patients using claims data from health insurance systems: A real-world comparative study
    Hongrui Tian
    Ruiping Xu
    Fenglei Li
    Chuanhai Guo
    Lixin Zhang
    Zhen Liu
    Mengfei Liu
    Yaqi Pan
    Zhonghu He
    Yang Ke
    ChineseJournalofCancerResearch, 2019, 31 (04) : 699 - 706
  • [39] Identification of cancer patients using claims data from health insurance systems: A real-world comparative study
    Tian, Hongrui
    Xu, Ruiping
    Li, Fenglei
    Guo, Chuanhai
    Zhang, Lixin
    Liu, Zhen
    Liu, Mengfei
    Pan, Yaqi
    He, Zhonghu
    Ke, Yang
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (04) : 699 - +
  • [40] REAL-WORLD PERSISTENCE ON CLADRIBINE TABLETS OF PATIENTS WITH RMS OVER 4 YEARS BASED ON CLAIMS DATA
    Giesl, N.
    Stahn, D.
    Osowski, U.
    VALUE IN HEALTH, 2023, 26 (12) : S505 - S506
12345